Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00924157 · ClinicalTrials.gov registry record · NA

Effect of Ile-Pro-Pro (IPP) on Endothelial Function in Patients With Coronary Artery Disease

A NA study of Coronary Artery Disease, sponsored by Boston University.

Completed
Registry status
NA
Development phase
54
Enrollment target
1
Study location

NCT00924157 is a NA study of Coronary Artery Disease that has completed, run by Boston University. The registered enrollment target is 54 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00924157, a NA study of Coronary Artery Disease, has completed, sponsored by Boston University.

COMPLETED
Registry status
NA
Development phase
54 participants
Enrollment target
1
Study location

Study Summary

This study will investigate whether the lacto-tripeptide Ile-Pro-Pro (IPP) improves the function of the endothelium in patients with coronary artery disease. The study has a crossover design. Participants will be treated with a protein hydrolysate rich in IPP for 12 weeks and placebo for 12 weeks with a four-week rest period between treatment periods. The investigators will use ultrasound to test the function of the endothelium in the brachial artery before, after 6 weeks, and after 12 weeks of each treatment. Blood will be collected before and after each treatment. The investigators hypothesize that IPP will improve endothelial function.

Conditions Studied

Coronary Artery Disease

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT IPP

Study Locations (1)

Massachusetts

  • Boston University Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2009-07
Est. Completion 2012-05
Phase NA

Sponsor

Boston University

185 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00924157

The ClinicalTrials.gov registry entry for NCT00924157 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (96% lower). The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00924157 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00924157 about?

NCT00924157 is a clinical study titled "Effect of Ile-Pro-Pro (IPP) on Endothelial Function in Patients With Coronary Artery Disease". This study will investigate whether the lacto-tripeptide Ile-Pro-Pro (IPP) improves the function of the endothelium in patients with coronary artery disease. The study has a crossover design. Participants will be treated with a protein hydrolysate rich in IPP for 12 weeks and placebo for 12 weeks wi...

What is the current status of trial NCT00924157?

This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2009-07. Estimated completion is 2012-05.

What conditions does trial NCT00924157 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT00924157?

The interventions under investigation include: Placebo (OTHER), IPP (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00924157?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00924157 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.